Sector News

Air Liquide enters Saudi Arabia’s home healthcare market

January 4, 2018
Energy & Chemical Value Chain

With the acquisition of the respiratory division of Thimar Al Jazirah Company (TAC) in Saudi Arabia, Air Liquide enters the Home Healthcare market in the Kingdom, and expands its Healthcare activity in the Middle East.

TAC is a leading actor in the pharmaceutical, medical and dental industries within the Kingdom of Saudi Arabia (KSA). Acquired through a majority equity stake (60%), the TAC Home Healthcare division specializes in the distribution of respiratory equipments and sleep disorder diagnosis services for patients suffering from respiratory conditions (sleep apnea, ventilation, chronic respiratory failure). TAC is the main player in this field in Saudi Arabia, serving over 1,400 patients at home throughout the country. The Home Healthcare division of TAC generated a revenue of over €5.5 million in 2016.

This acquisition reinforces the healthcare position of Air Liquide in Saudi Arabia, where it already supplies medical gases to hospitals. It also represents the entry into a territory with high potential for Air Liquide’s Home Healthcare activity. The acquired entity has joined VitalAire, Air Liquide’s global brand for Home Healthcare.

With a population of over 32 million, rising healthcare needs and a commitment from public authorities to improve the quality of healthcare services in the Kingdom, the healthcare sector in KSA presents a strong potential with notably an increasing opening to foreign investors driven by the Saudi government’s 2030 Vision.

Francois Jackow, member of the Air Liquide Group’s Executive Committee, supervising Healthcare activities, said: “With this acquisition, Air Liquide pursues the development of its activity in Saudi Arabia and expands its Healthcare business in the Middle East. We are welcoming new TAC employees to Air Liquide’s operations and are looking forward to bringing high quality of service and first class innovations to patients in Saudi Arabia, as we do for more than 1.4 million patients around the world every day.”

Source: Air Liquide

comments closed

Related News

May 4, 2024

Heikki Malinen appointed as the President and CEO of Neste Corporation

Energy & Chemical Value Chain

Neste Corporation’s Board of Directors has appointed Heikki Malinen, M.Sc. (Econ.), MBA (Harvard) as the President and CEO of Neste as of 2 November 2024, at the latest. Malinen joins Neste from Outokumpu Corporation where he has held the position of President and CEO since 2020.

May 4, 2024

Rossouw to step down as Sasol CFO in October

Energy & Chemical Value Chain

Petrochemicals company Sasol has announced that CFO and executive director Hanré Rossouw will step down from his position, effective October 31. Sasol has started the process to appoint a successor. Rossouw will still oversee the publication of Sasol’s reports for the financial year ending June 30, to allow for a structured handover period.

May 4, 2024

Chemours CFO Jonathan Lock resigns following code of ethics violations

Energy & Chemical Value Chain

Chemours announced its CFO Jonathan Lock has resigned from all positions within the company, according to an SEC 8-K filing on April 23. The resignation comes in the aftermath of the company announcing that Lock, former CEO Mark Newman, and principal accounting officer Camela Wisel, had been placed on administrative leave.

How can we help you?

We're easy to reach